Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
ASCP Corner
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Dennis E. Sweitzer, PhD
JCP
Letter to the Editor
Reply to A Discussion of 2 Double-Blind Studies Comparing Risperidone and Quetiapine in Patients With Schizophrenia
February 15, 2007
Dennis E. Sweitzer
,
Arthur Lazarus
,
Martin Brecher
JCP
Original Research
Comparison of Quetiapine and Risperidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Flexible-Dose, 8-Week Study
July 14, 2006
Kate X. Zhong
,
Dennis E. Sweitzer
,
Robert M. Hamer
, et al
JCP
Original Research
Efficacy of Quetiapine and Risperidone Against Depressive Symptoms in Outpatients With Psychosis.
December 1, 2002
Martha Sajatovic
,
Jamie A. Mullen
,
Dennis E. Sweitzer
